<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font30">the </span>
   <span class="font20">for </span>
   <span class="font18">hepatitis </span>
   <span class="font17">HCV </span>
   <span class="font17">with </span>
   <span class="font16">virus </span>
   <span class="font15">are </span>
   <span class="font14">resistance </span>
   <span class="font14">treatment </span>
   <span class="font13">{background </span>
   <span class="font13">patients </span>
   <span class="font13">genotype </span>
   <span class="font13">antiviral </span>
   <span class="font13">testing </span>
   <span class="font12">The </span>
   <span class="font12">NSA </span>
   <span class="font12">margin </span>
   <span class="font12">viral </span>
   <span class="font12">{border-style </span>
   <span class="font12">chronic </span>
   <span class="font12">clinical </span>
   <span class="font12">considered </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">drug </span>
   <span class="font12">infection </span>
   <span class="font12">protein </span>
   <span class="font12">Hepatitis </span>
   <span class="font12">RAS </span>
   <span class="font12">recommended </span>
   <span class="font11">RASs </span>
   <span class="font11">can </span>
   <span class="font11">has </span>
   <span class="font11">NSB </span>
   <span class="font11">from </span>
   <span class="font11">inhibitor </span>
   <span class="font11">not </span>
   <span class="font11">therapy </span>
   <span class="font11">Virol </span>
   <span class="font11">being </span>
   <span class="font11">polymerase </span>
   <span class="font11">protease </span>
   <span class="font11">that </span>
   <span class="font11">DAA </span>
   <span class="font11">cirrhosis </span>
   <span class="font11">replication </span>
   <span class="font11">Genotype </span>
   <span class="font11">However, </span>
   <span class="font11">been </span>
   <span class="font11">should </span>
   <span class="font11">substitutions </span>
   <span class="font11">which </span>
   <span class="font11">DAAs </span>
   <span class="font11">management </span>
   <span class="font11">proteins </span>
   <span class="font11">ribavirin </span>
   <span class="font11"> NSA </span>
   <span class="font11">NS/A </span>
   <span class="font11">Table </span>
   <span class="font11">infected </span>
   <span class="font11">prevalence </span>
   <span class="font11">px; </span>
   <span class="font11">therapy. </span>
   <span class="font11">these </span>
   <span class="font11">variants </span>
   <span class="font11">{font-family </span>
   <span class="font10">RNA </span>
   <span class="font10">cell </span>
   <span class="font10">drugs </span>
   <span class="font10">font-size </span>
   <span class="font10">found </span>
   <span class="font10">genotypes </span>
   <span class="font10">important </span>
   <span class="font10">inhibitors </span>
   <span class="font10">review </span>
   <span class="font10">role </span>
   <span class="font10">This </span>
   <span class="font10">agents </span>
   <span class="font10">amino </span>
   <span class="font10">associated </span>
   <span class="font10">common </span>
   <span class="font10">different </span>
   <span class="font10">double; </span>
   <span class="font10">emerging </span>
   <span class="font10">interferon </span>
   <span class="font10">its </span>
   <span class="font10">may </span>
   <span class="font10">presence </span>
   <span class="font10">present, </span>
   <span class="font10">reported </span>
   <span class="font10">sequencing </span>
   <span class="font10">their </span>
   <span class="font10">this </span>
   <span class="font10">treatment-naive </span>
   <span class="font10">viruses </span>
   <span class="font10">vitro </span>
   <span class="font10">weeks </span>
   <span class="font10">Med </span>
   <span class="font10">Nonstructural </span>
   <span class="font10">SVR </span>
   <span class="font10">Structural </span>
   <span class="font10">Viral </span>
   <span class="font10">acid </span>
   <span class="font10">acting </span>
   <span class="font10">all </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">direct </span>
   <span class="font10">direct-acting </span>
   <span class="font10">dominant </span>
   <span class="font10">epidemiology </span>
   <span class="font10">existing </span>
   <span class="font10">global </span>
   <span class="font10">have </span>
   <span class="font10">healthcare </span>
   <span class="font10">into </span>
   <span class="font10">like </span>
   <span class="font10">nucleotide </span>
   <span class="font10">present </span>
   <span class="font10">rates </span>
   <span class="font10">result </span>
   <span class="font10">solid; </span>
   <span class="font10">standard </span>
   <span class="font10">used </span>
   <span class="font10">weight-based </span>
   <span class="font10">wild-type </span>
   <span class="font10">without </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10"> RAS </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">-infected, </span>
   <span class="font10">Clin </span>
   <span class="font10">Europe </span>
   <span class="font10">Europe, </span>
   <span class="font10">Gastroenterol </span>
   <span class="font10">High </span>
   <span class="font10">India, </span>
   <span class="font10">Liver </span>
   <span class="font10">Low </span>
   <span class="font10">a-infected, </span>
   <span class="font10">about </span>
   <span class="font10">action </span>
   <span class="font10">after </span>
   <span class="font10">analysis </span>
   <span class="font10">any </span>
   <span class="font10">barrier </span>
   <span class="font10">bold </span>
   <span class="font10">clinically </span>
   <span class="font10">core </span>
   <span class="font10">courier; </span>
   <span class="font10">develop </span>
   <span class="font10">em; </span>
   <span class="font10">generation </span>
   <span class="font10">hepatic </span>
   <span class="font10">high </span>
   <span class="font10">lower </span>
   <span class="font10">many </span>
   <span class="font10">more </span>
   <span class="font10">most </span>
   <span class="font10">new </span>
   <span class="font10">nonstructural </span>
   <span class="font10">plus </span>
   <span class="font10">potency </span>
   <span class="font10">potential </span>
   <span class="font10">prevalent </span>
   <span class="font10">primary </span>
   <span class="font10">pt;} </span>
   <span class="font10">quasispecies </span>
   <span class="font10">region </span>
   <span class="font10">relevance </span>
   <span class="font10">replicative </span>
   <span class="font10">ribavirin, </span>
   <span class="font10">services </span>
   <span class="font10">such </span>
   <span class="font10">than </span>
   <span class="font10">treatment-experienced </span>
   <span class="font10">various </span>
   <span class="font10">were </span>
  </p>
 </body>
</html>
